Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

Share Price is delayed by 15 minutes
Get Live Data
12.60    -0.05 (-0.40%)
Bid:
12.60
Ask:
12.95
Spread: 0.35 (2.778%)
Market Cap: £42.85m
BVC Live PriceLast checked at - London Stock Exchange

Intraday Batm Advanced Share Chart

Interim Management Statement

12 May 2009 07:00

RNS Number : 0495S
BATM Advanced Communications Ld
12 May 2009
 



BATM Advanced Communications Limited

Interim Management Statement

BATM Advanced Communications Limited ("BATM" or "the Company") (LSE: BVC), a leading designer and producer of Carrier Ethernet and metropolitan telecom systems, is today issuing its first Interim Management Statement for financial year 2009 which covers the period from 1 January 2009 to 30 April 2009.

Current trading update 

Total revenues in the first four months of 2009 were broadly in line with the same period in 2008. As expected, revenues in the telecom sector were lower in US$ terms than last year's record comparable period, while revenues in the medical sector continue to grow and were higher than last year, partially as a result of the acquisitions made in 2008 and 2009. The gross margin in the first four months has fallen slightly compared to H2 2008 as a result of a continued weakening of the Euro and the higher percentage of medical equipment of overall sales.

Financial position 

The Company's balance sheet remains very strong and at the end of April the effective cash balance stood at $61.7 million, an improvement of $4.4 million compared to the position at the beginning of the financial year

Acquisition of clinical chemistry diagnostic company:

Apreviously announced with the Company's final results for the year ended 31 December 2008in February 2009 BATM acquired a controlling interest in an Italian clinical chemistry diagnostics Company called ISE.  The directors believe that this transaction will strengthen the Company's future position in the medical equipment offering, and will allow it to realize synergies with its existing medical business in Eastern Europe.

Outlook Despite the general market conditions and lower profitability in the first four months of the year, thCompany has seen an improvement in its order book recently, which leads the management to remain cautiously optimistic that BATM will meet its targets for the full year.

- ends -

Enquiries

BATM Advanced Communications

Dr Zvi Marom, Chief Executive

+972 9866 2525

Threadneedle Communications

Josh Royston / Graham Herring

020 7653 9850

Singer Capital Markets Ltd

Nicholas How

020 3205 7620 

Shore Capital

Graham Shore

020 7408 4090 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBSGDURSBGGCB
Date   Source Headline
26th May 20267:00 amRNSBlock Listing Interim Review
21st Apr 20267:00 amRNSPublication of Annual Report
11th Mar 20267:00 amRNSFull Year Results
3rd Mar 202612:00 pmRNSHolding(s) in Company
10th Feb 20267:00 amRNSSale of Non-core Business
3rd Feb 20267:00 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSHolding(s) in Company
19th Jan 20267:00 amRNS-RBATM selected as FPT Israel cybersecurity partner
12th Jan 20267:00 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSHolding(s) in Company
8th Jan 202611:00 amRNSTransaction in own shares and Total Voting Rights
2nd Jan 20267:01 amRNSDirector Declaration
2nd Jan 20267:01 amRNSDirector Declaration
2nd Jan 20267:00 amRNSCompletion of Sale of Diagnostics Distributor
2nd Jan 20267:00 amRNSCompletion of Sale of Diagnostics Distributor
29th Dec 20257:00 amRNSAppointment of Chairman and Directorate Change
29th Dec 20257:00 amRNSAppointment of Chairman and Directorate Change
10th Dec 202512:00 pmRNSAGM Result, Directorate Change & AMS Sale Update
1st Dec 20257:00 amRNSTotal Voting Rights
25th Nov 20257:00 amRNSBlock Listing Interim Review
17th Nov 20257:00 amRNSNew Carrier Ethernet Order
5th Nov 20257:00 amRNSNotice of AGM and Directorate Changes
6th Oct 20257:00 amRNSSale of Diagnostics Distributor
26th Sep 20257:00 amRNSDirectorate Change
18th Aug 20257:00 amRNSInterim Results
4th Aug 20257:00 amRNSTotal Voting Rights
24th Jul 20257:00 amRNSSale of Non-Core Businesses and Notice of Results
23rd Jun 20257:00 amRNSDirectorate Change
27th May 20257:00 amRNSBlock Listing Interim Review
12th May 20257:00 amRNSOrder for ultra-high speed encryption development
6th May 20257:00 amRNS-RBATM unveils new brand identity
8th Apr 202511:00 amRNSAnnual Report Publication and AGM Update Statement
27th Mar 20257:00 amRNSNew strategic customer for Edgility in Brazil
17th Mar 20257:00 amRNSFull Year Results
5th Mar 20257:00 amRNSUpdate on Strategy and Trading
24th Feb 20257:00 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSADOR appoints Nadhim Zahawi to lead Advisory Board
19th Dec 20243:30 pmRNSResult of AGM and Director Appointment
19th Dec 20247:00 amRNSNew Tier 1 Customer for Edgility in Mexico
11th Dec 20247:00 amRNSNATlab commences pre-clinical validation
3rd Dec 20247:00 amRNSBlock Listing Interim Review
2nd Dec 20247:00 amRNSBATM receives orders of $2.4m for Edgility
25th Nov 20247:00 amRNSBlock listing Interim Review
14th Nov 202411:00 amRNSNotice of AGM and Proposed Director Appointment
4th Nov 20247:00 amRNSTotal Voting Rights
19th Aug 20247:00 amRNSInterim Results
10th Jul 20247:00 amRNSAmazon Web Services partnership for Edgility
2nd Jul 20247:00 amRNSCommercial markets cybersecurity partnership
3rd Jun 20247:00 amRNSBlock Listing Interim Review
28th May 20247:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.